{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T21:59:56Z","timestamp":1790459996947,"version":"4.1.0"},"reference-count":83,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.3892\/mmr.2015.3658","type":"journal-article","created":{"date-parts":[[2015,4,22]],"date-time":"2015-04-22T03:17:17Z","timestamp":1429672637000},"page":"1617-1624","source":"Crossref","is-referenced-by-count":31,"title":["Apolipoprotein M: Research progress, regulation and metabolic functions (Review)"],"prefix":"10.3892","volume":"12","author":[{"given":"LI-ZHU","family":"HUANG","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JIA-LIN","family":"GAO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CHUN","family":"PU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PU-HONG","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LI-ZHUO","family":"WANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GANG","family":"FENG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YAO","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2015,4,22]]},"reference":[{"key":"key20180108021920_b1-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"31286","DOI":"10.1074\/jbc.274.44.31286","article-title":"A novel human apolipoprotein (apoM)","volume":"274","author":"Xu","year":"1999","journal-title":"J Biol Chem"},{"key":"key20180108021920_b2-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1194\/jlr.M600055-JLR200","article-title":"Isolation and characterization of human apolipoprotein M-containing lipoproteins","volume":"47","author":"Christoffersen","year":"2006","journal-title":"J Lipid Res"},{"key":"key20180108021920_b3-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1194\/jlr.M700113-JLR200","article-title":"An ELISA for apolipoprotein M reveals a strong correlation to total cholesterol in human plasma","volume":"48","author":"Axler","year":"2007","journal-title":"J Lipid Res"},{"key":"key20180108021920_b4-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1078\/0065-1281-00687","article-title":"Specific tissue expression and cellular localization of human apolipoprotein M as determined by in situ hybridization","volume":"105","author":"Zhang","year":"2003","journal-title":"Acta Histochem"},{"key":"key20180108021920_b5-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.acthis.2003.11.004","article-title":"Expression pattern of apolipoprotein M during mouse and human embryogenesis","volume":"106","author":"Zhang","year":"2004","journal-title":"Acta Histochem"},{"key":"key20180108021920_b6-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1194\/jlr.M300451-JLR200","article-title":"Characterization of apoM in normal and genetically modified mice","volume":"45","author":"Faber","year":"2004","journal-title":"J Lipid Res"},{"key":"key20180108021920_b7-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/pro.5560020507","article-title":"Structure and sequence relationships in the lipocalins and related proteins","volume":"2","author":"Flower","year":"1993","journal-title":"Protein Sci"},{"key":"key20180108021920_b8-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1161\/01.ATV.19.9.2214","article-title":"Human serum Paraoxonase\/Arylesterase\u2019s retained hydrophobic N-terminal leader sequence associates with HDLs by binding phospholipids: apolipoprotein A-I stabilizes activity","volume":"19","author":"Sorenson","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key20180108021920_b9-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.febslet.2008.02.007","article-title":"Apolipoprotein M associates to lipoproteins through its retained signal peptide","volume":"582","author":"Axler","year":"2008","journal-title":"FEBS Lett"},{"key":"key20180108021920_b10-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0014-5793(01)02544-3","article-title":"Proposed lipocalin fold for apolipoprotein M based on bioinformatics and site-directed mutagenesis","volume":"499","author":"Duan","year":"2001","journal-title":"FEBS Lett"},{"key":"key20180108021920_b11-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"18765","DOI":"10.1074\/jbc.M800695200","article-title":"The signal peptide anchors apolipoprotein M in plasma lipoproteins and prevents rapid clearance of apolipoprotein M from plasma","volume":"283","author":"Christoffersen","year":"2008","journal-title":"J Biol Chem"},{"key":"key20180108021920_b12-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0167-4838(00)00148-5","article-title":"The lipocalin protein family: structural and sequence overview","volume":"1482","author":"Flower","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"key20180108021920_b13-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.jmb.2009.08.071","article-title":"Serendipitous fatty acid binding reveals the structural determinants for ligand recognition in apolipoprotein M","volume":"393","author":"Sevvana","year":"2009","journal-title":"J Mol Biol"},{"key":"key20180108021920_b14-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1194\/jlr.M700103-JLR200","article-title":"Hydrophobic ligand binding properties of the human lipocalin apolipoprotein M","volume":"48","author":"Ahnstr\u00f6m","year":"2007","journal-title":"J Lipid Res"},{"key":"key20180108021920_b15-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"9613","DOI":"10.1073\/pnas.1103187108","article-title":"Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M","volume":"108","author":"Christoffersen","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180108021920_b16-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1210\/me.2005-0209","article-title":"Megalin is a receptor for apolipoprotein M and kidney-specific megalin-deficiency confers urinary excretion of apolipoprotein M","volume":"20","author":"Faber","year":"2006","journal-title":"Mol Endocrinol"},{"key":"key20180108021920_b17-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1021\/pr060180x","article-title":"Characterization of apolipoprotein M isoforms in low-density lipoprotein","volume":"5","author":"Karlsson","year":"2006","journal-title":"J Proteome Res"},{"key":"key20180108021920_b18-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.1016\/j.chroma.2010.09.027","article-title":"Hydrophilic interaction chromatography of intact, soluble proteins","volume":"1218","author":"Tetaz","year":"2011","journal-title":"J Chromatogr A"},{"key":"key20180108021920_b19-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1006\/bbrc.2002.6755","article-title":"Effects of platelet-activating factor, tumor necrosis factor and interleukin-1alpha on the expression of apolipoprotein M in HepG2 cells","volume":"292","author":"Xu","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180108021920_b20-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.bbalip.2004.04.001","article-title":"Transforming growth factor-beta down-regulates apolipoprotein M in HepG2 cells","volume":"1683","author":"Xu","year":"2004","journal-title":"Biochim Biophys Acta"},{"key":"key20180108021920_b21-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1634\/stemcells.2008-0148","article-title":"Hepatocyte nuclear factor-1 as marker of epithelial phenotype reveals marrow-derived hepatocytes, but not duct cells, after liver injury in mice","volume":"26","author":"Swenson","year":"2008","journal-title":"Stem Cells"},{"key":"key20180108021920_b22-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.2337\/diabetes.52.12.2989","article-title":"Regulation of apolipoprotein M gene expression by MODY3 gene hepatocyte nuclear factor-1alpha: haploinsufficiency is associated with reduced serum apolipoprotein M levels","volume":"52","author":"Richter","year":"2003","journal-title":"Diabetes"},{"key":"key20180108021920_b23-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/86871","article-title":"Hepatocyte nuclear factor-1alpha is an essential regulator of bile acid and plasma cholesterol metabolism","volume":"27","author":"Shih","year":"2001","journal-title":"Nat Genet"},{"key":"key20180108021920_b24-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"17259","DOI":"10.1074\/jbc.M110.200659","article-title":"Opposite regulation of the human apolipoprotein M gene by hepatocyte nuclear factor 1 and Jun transcription factors","volume":"286","author":"Mosialou","year":"2011","journal-title":"J Biol Chem"},{"key":"key20180108021920_b25-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.1074\/jbc.M706382200","article-title":"Regulation of anti-atherogenic apolipoprotein M gene expression by the orphan nuclear receptor LRH-1","volume":"283","author":"Venteclef","year":"2008","journal-title":"J Biol Chem"},{"key":"key20180108021920_b26-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1124\/mi.2.2.78","article-title":"LuXuRies of lipid homeostasis: the unity of nuclear hormone receptors, transcription regulation, and cholesterol sensing","volume":"2","author":"Zhang","year":"2002","journal-title":"Mol Interv"},{"key":"key20180108021920_b27-mmr-12-02-1617","first-page":"121","article-title":"Effect of interfering hepatocyte nuclear factor-1 alfa in HepG2 on the expressions of apoM, apoA-I and the correlative key enzyme of cholesterol metabolism","volume":"19","author":"Zhang","year":"2011","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"key20180108021920_b28-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"516","DOI":"10.2174\/138920108786786376","article-title":"LXR-agonists regulate ApoM expression differentially in liver and intestine","volume":"9","author":"Calayir","year":"2008","journal-title":"Curr Pharm Biotechnol"},{"key":"key20180108021920_b29-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1388-1981(01)00162-7","article-title":"Cellular cholesterol efflux","volume":"1533","author":"Fielding","year":"2001","journal-title":"Biochim Biophys Acta"},{"key":"key20180108021920_b30-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.bbrc.2012.04.022","article-title":"ABCA1 upregulating apolipoproein M expression mediates via the RXR\/lXR pathway in HepG2 cells","volume":"421","author":"Di","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180108021920_b31-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.bbrc.2008.04.017","article-title":"Liver X receptor agonist downregulates hepatic apoM expression in vivo and in vitro","volume":"371","author":"Zhang","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180108021920_b32-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"30719","DOI":"10.1074\/jbc.M110.131771","article-title":"Regulation of human apolipoprotein m gene expression by orphan and ligand-dependent nuclear receptors","volume":"285","author":"Mosialou","year":"2010","journal-title":"J Biol Chem"},{"key":"key20180108021920_b33-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/1476-511X-11-168","article-title":"Dihydrotestosterone regulating apolipoprotein M expression mediates via protein kinase C in HepG2 cells","volume":"11","author":"Yi-Zhou","year":"2012","journal-title":"Lipids Health Dis"},{"key":"key20180108021920_b34-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1749-6632.2000.tb06305.x","article-title":"Receptors and lipid transfer proteins in HDL metabolism","volume":"902","author":"Silver","year":"2000","journal-title":"Ann NY Acad Sci"},{"key":"key20180108021920_b35-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0021-9150(99)00065-9","article-title":"Atheroprotective mechanisms of HDL","volume":"144","author":"Stein","year":"1999","journal-title":"Atherosclerosis"},{"key":"key20180108021920_b36-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev.med.54.101601.152409","article-title":"Atheroprotective effects of high-density lipoproteins","volume":"54","author":"Assmann","year":"2003","journal-title":"Annu Rev Med"},{"issue":"Suppl","key":"key20180108021920_b37-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0021-9150(97)00312-2","article-title":"Mechanisms of high density lipoprotein-mediated efflux of cholesterol from cell plasma membranes","volume":"137","author":"Phillips","year":"1998","journal-title":"Atherosclerosis"},{"key":"key20180108021920_b38-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/00041433-200006000-00007","article-title":"Lecithin-cholesterol acyltransferase: role in lipoprotein metabolism, reverse cholesterol transport and atherosclerosis","volume":"11","author":"Santamarina-Fojo","year":"2000","journal-title":"Curr Opin Lipidol"},{"key":"key20180108021920_b39-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/S0022-2275(20)38234-1","article-title":"Transfer of cholesteryl ester into high density lipoprotein by cholesteryl ester transfer protein: effect of HDL lipid and apoprotein content","volume":"30","author":"Sparks","year":"1989","journal-title":"J Lipid Res"},{"key":"key20180108021920_b40-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1161\/CIRCRESAHA.109.211086","article-title":"Opposing effects of apolipoprotein m on catabolism of apolipoprotein B-containing lipoproteins and atherosclerosis","volume":"106","author":"Christoffersen","year":"2010","journal-title":"Circ Res"},{"key":"key20180108021920_b41-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1074\/jbc.M704576200","article-title":"Effect of apolipoprotein M on high density lipoprotein metabolism and atherosclerosis in low density lipoprotein receptor knock-out mice","volume":"283","author":"Christoffersen","year":"2008","journal-title":"J Biol Chem"},{"key":"key20180108021920_b42-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/nm1211","article-title":"Apolipoprotein M is required for prebeta-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis","volume":"11","author":"Wolfrum","year":"2005","journal-title":"Nat Med"},{"key":"key20180108021920_b43-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1194\/jlr.M700471-JLR200","article-title":"Levels of apolipoprotein M are not associated with the risk of coronary heart disease in two independent case-control studies","volume":"49","author":"Ahnstr\u00f6m","year":"2008","journal-title":"J Lipid Res"},{"key":"key20180108021920_b44-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"12538","DOI":"10.1021\/bi025998k","article-title":"Evidence that phospholipids play a key role in pre-beta apoA-I formation and high-density lipoprotein remodeling","volume":"41","author":"Rye","year":"2002","journal-title":"Biochemistry"},{"key":"key20180108021920_b45-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1074\/jbc.M704576200","article-title":"Effect of apolipoprotein M on high density lipoprotein metabolism and atherosclerosis in low density lipoprotein receptor knock-out mice","volume":"283","author":"Christoffersen","year":"2008","journal-title":"J Biol Chem"},{"key":"key20180108021920_b46-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.atherosclerosis.2011.11.031","article-title":"Apolipoprotein M binds oxidized phospholipids and increases the antioxidant effect of HDL","volume":"221","author":"Els\u00f8e","year":"2012","journal-title":"Atherosclerosis"},{"key":"key20180108021920_b47-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.bbalip.2013.04.009","article-title":"Apolipoprotein M promotes mobilization of cellular cholesterol in vivo","volume":"1831","author":"Els\u00f8e","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"key20180108021920_b48-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.mehy.2006.10.052","article-title":"Apolipoprotein M likely extends its anti-atherogenesis via anti-inflammation","volume":"69","author":"Huang","year":"2007","journal-title":"Med Hypotheses"},{"key":"key20180108021920_b49-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/cc11320","article-title":"Apolipoprotein M-a new biomarker in sepsis","volume":"16","author":"Christoffersen","year":"2012","journal-title":"Crit Care"},{"key":"key20180108021920_b50-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"R60","DOI":"10.1186\/cc11305","article-title":"Decreased plasma concentrations of apolipoprotein M in sepsis and systemic inflammatory response syndromes","volume":"16","author":"Kumaraswamy","year":"2012","journal-title":"Crit Care"},{"key":"key20180108021920_b51-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00395-010-0112-5","article-title":"Sphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery disease","volume":"105","author":"Sattler","year":"2010","journal-title":"Basic Res Cardiol"},{"key":"key20180108021920_b52-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.3390\/ijms14034419","article-title":"The apolipoprotein m-sphin-gosine-1-phosphate axis: biological relevance in lipoprotein metabolism, lipid disorders and atherosclerosis","volume":"14","author":"Arkensteijn","year":"2013","journal-title":"Int J Mol Sci"},{"key":"key20180108021920_b53-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.atherosclerosis.2013.04.024","article-title":"Liver involvement in sphingosine 1-phosphate dynamism revealed by adenoviral hepatic overexpression of apolipoprotein M","volume":"229","author":"Kurano","year":"2013","journal-title":"Atherosclerosis"},{"key":"key20180108021920_b54-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1440-1681.2007.04822.x","article-title":"A genetic variant of apolipoprotein M increases susceptibility to coronary artery disease in a Chinese population","volume":"35","author":"Xu","year":"2008","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"key20180108021920_b55-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.clinbiochem.2007.04.023","article-title":"A prospective evaluation of apolipoprotein M gene T-778C polymorphism in relation to coronary artery disease in Han Chinese","volume":"40","author":"Jiao","year":"2007","journal-title":"Clin Biochem"},{"key":"key20180108021920_b56-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1476-511X-12-135","article-title":"Apolipoprotein M T-778C polymorphism is associated with serum lipid levels and the risk of coronary artery disease in the Chinese population: a meta-analysis","volume":"12","author":"Zhang","year":"2013","journal-title":"Lipids Health Dis"},{"issue":"Suppl 1","key":"key20180108021920_b57-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1463-1326.2008.01004.x","article-title":"Identification of T1D susceptibility genes within the MHC region by combining protein interaction networks and SNP genotyping data","volume":"11","author":"Brorsson","year":"2009","journal-title":"Diabetes Obes Metab"},{"key":"key20180108021920_b58-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.clinbiochem.2008.10.008","article-title":"Apolipoprotein M promoter polymorphisms alter promoter activity and confer the susceptibility to the development of type 1 diabetes","volume":"42","author":"Wu","year":"2009","journal-title":"Clin Biochem"},{"key":"key20180108021920_b59-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"e17324","DOI":"10.1371\/journal.pone.0017324","article-title":"Apolipoprotein M gene (APOM) polymorphism modifies metabolic and disease traits in type 2 diabetes","volume":"6","author":"Zhou","year":"2011","journal-title":"PLoS One"},{"key":"key20180108021920_b60-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/372425a0","article-title":"Positional cloning of the mouse obese gene and its human homologue","volume":"372","author":"Zhang","year":"1994","journal-title":"Nature"},{"key":"key20180108021920_b61-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev.physiol.62.1.413","article-title":"Leptin","volume":"62","author":"Ahima","year":"2000","journal-title":"Annu Rev Physiol"},{"key":"key20180108021920_b62-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jnutbio.2004.03.001","article-title":"Correlation of apolipoprotein M with leptin and cholesterol in normal and obese subjects","volume":"15","author":"Xu","year":"2004","journal-title":"J Nutr Biochem"},{"key":"key20180108021920_b63-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.bbrc.2004.06.180","article-title":"Both leptin and leptin-receptor are essential for apolipoprotein M expression in vivo","volume":"321","author":"Xu","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180108021920_b64-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.bbalip.2005.02.005","article-title":"Leptin inhibits apolipoprotein M transcription and secretion in human hepatoma cell line, HepG2 cells","volume":"1734","author":"Luo","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"key20180108021920_b65-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.atherosclerosis.2009.11.024","article-title":"Association of apolipoprotein M with high-density lipoprotein kinetics in overweight-obese men","volume":"210","author":"Ooi","year":"2010","journal-title":"Atherosclerosis"},{"key":"key20180108021920_b66-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.atherosclerosis.2010.10.041","article-title":"Relationship of plasma apolipoprotein M with proprotein convertase subtilisin-kexin type 9 levels in non-diabetic subjects","volume":"214","author":"Kappelle","year":"2011","journal-title":"Atherosclerosis"},{"key":"key20180108021920_b67-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1365-2796.2009.02145.x","article-title":"An investigation of serum concentration of apoM as a potential MODY3 marker using a novel ELISA","volume":"267","author":"Cervin","year":"2010","journal-title":"J Intern Med"},{"key":"key20180108021920_b68-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/dme.12066","article-title":"Apolipoprotein M can discriminate HNF1A-MODY from Type 1 diabetes","volume":"30","author":"Mughal","year":"2013","journal-title":"Diabet Med"},{"key":"key20180108021920_b69-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.bbrc.2006.02.022","article-title":"Suppression of apolipoprotein M expression and secretion in alloxan-diabetic mouse: Partial reversal by insulin","volume":"342","author":"Xu","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180108021920_b70-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.bbalip.2007.04.020","article-title":"Hyperglycemia down-regulates apolipoprotein M expression in vivo and in vitro","volume":"1771","author":"Zhang","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"key20180108021920_b71-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.bbalip.2006.02.002","article-title":"Down-regulation of apolipoprotein M expression is mediated by phosphatidylinositol 3-kinase in HepG2 cells","volume":"1761","author":"Xu","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"key20180108021920_b72-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"16940","DOI":"10.1074\/jbc.M801930200","article-title":"Foxa2 activity increases plasma high density lipoprotein levels by regulating apolipoprotein M","volume":"283","author":"Wolfrum","year":"2008","journal-title":"J Biol Chem"},{"key":"key20180108021920_b73-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1476-511X-9-102","article-title":"Expression and localization of apolipoprotein M in human colorectal tissues","volume":"9","author":"Luo","year":"2010","journal-title":"Lipids Health Dis"},{"key":"key20180108021920_b74-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/1476-511X-10-154","article-title":"Enchanced levels of apolipoprotein M during HBV infection feedback suppresses HBV replication","volume":"10","author":"Gu","year":"2011","journal-title":"Lipids Health Dis"},{"key":"key20180108021920_b75-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.acthis.2009.08.005","article-title":"Expression of apolipoprotein M in human hepatocellular carcinoma tissues","volume":"113","author":"Jiang","year":"2011","journal-title":"Acta Histochem"},{"key":"key20180108021920_b76-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/j.transproceed.2006.08.133","article-title":"Effects of ischemia-reperfusion injury on apolipoprotein M expression in the liver","volume":"38","author":"Xu","year":"2006","journal-title":"Transplant Proc"},{"key":"key20180108021920_b77-mmr-12-02-1617","first-page":"180","article-title":"The APOM polymorphism as a novel risk factor for dyslipidaemia in rheumatoid arthritis: a possible shared link between disease susceptibility and dyslipidaemia","volume":"31","author":"Park","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"key20180108021920_b78-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s12031-010-9453-7","article-title":"Association of apolipoprotein M gene polymorphisms with ischemic stroke in a Han Chinese population","volume":"43","author":"Zhao","year":"2011","journal-title":"J Mol Neurosci"},{"key":"key20180108021920_b79-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1183\/09031936.00147612","article-title":"APOM and high-density lipoprotein cholesterol are associated with lung function and per cent emphysema","volume":"43","author":"Burkart","year":"2014","journal-title":"Eur Respir J"},{"key":"key20180108021920_b80-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1365-2869.2008.00725.x","article-title":"Increase in serum haptoglobin and apolipoprotein M in patients with obstructive sleep apnoea","volume":"18","author":"Kim","year":"2009","journal-title":"J Sleep Res"},{"key":"key20180108021920_b81-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.cca.2009.06.010","article-title":"Plasma apolipoprotein M is reduced in metabolic syndrome but does not predict intima media thickness","volume":"406","author":"Dullaart","year":"2009","journal-title":"Clin Chim Acta"},{"key":"key20180108021920_b82-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.clinbiochem.2009.11.006","article-title":"Plasma concentrations of apolipoproteins A-I, B and M in patients with abdominal aortic aneurysms","volume":"43","author":"Ahnstr\u00f6m","year":"2010","journal-title":"Clin Biochem"},{"key":"key20180108021920_b83-mmr-12-02-1617","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.clinbiochem.2010.01.001","article-title":"Plasma concentrations of apolipoproteins A-I, B and M in patients with critical limb ischemia","volume":"43","author":"Ahnstr\u00f6m","year":"2010","journal-title":"Clin Biochem"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mmr.2015.3658\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T14:54:41Z","timestamp":1651762481000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2015.3658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,22]]},"references-count":83,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2015,4,22]]},"published-print":{"date-parts":[[2015,8]]}},"alternative-id":["10.3892\/mmr.2015.3658"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2015.3658","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,22]]}}}